New app called GDm-Health was reported to be effective in self-monitoring tool of gestational diabetes, which could improve outcomes for pregnant women
The app is designed by health-tech company Drayson Health in collaboration with the University of Oxford and the Oxford University Hospitals NHS Foundation Trust. GDm-Health is an NHS-approved app for tracking blood sugar levels in woman with hyperglycemia during pregnancy. Users can download and share the data with healthcare providers on their smartphones after measuring the glucose level.
It follows a series of patient self-care initiatives aimed at tackling diabetes, including a large-scale effort spearheaded by NHS Digital. The trial was funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. Around 203 patients were involved in the study. The study reports significant reduction in pre-mature births for patients who used GDm-Health, However the researchers concluded that this did not reach statistical significance. Dr Lucy Mackillop, consultant obstetric physician at Oxford University Hospitals NHS Foundation and lead author of the paper, said the study “demonstrates the potential utility of GDm-Health to improve care and outcomes for women with gestational diabetes and their babies”.
Professor Lionel Tarassenko, head of engineering science at the University of Oxford, said: “This trial is another example of how self-management by patients using digital health tools can be secure, gives them greater control of their condition and reduces the number of times they have to visit clinic. “It improves communication between patient and clinical staff, reduces the amount of time spent by nurses and midwives on administrative tasks and allows for accurate auditing of data about care and outcomes.”